Posters Presented in 2006

A Phase I/II Study of Arsenic Trioxide, Bortezomib,
and Ascorbic Acid in Relapsed or Refractory Multiple Myeloma
Presented at ASCO 2006


Click here to download the results of this study


Phase I Study of Bortezomib and 153SM-lexidronam
Combination for Refractory and Relapsed Multiple Myeloma
Presented at ASCO 2006


Click here to download the results of this study


Phase I Study of Zio-101: a Novel Organic Arsenic Active
in Acute Myelogenous Leukemia (AML) and Multiple Myeloma (MM)
Presented at ASH 2006


Click here to download the results of this study


Phase I Study of Bortezomib and 153SM-lexidronam
Combination for Refractory and Relapsed Multiple Myeloma
Presented at ASH 2006


Click here to download the results of this study